Here are four things to know:
1. This is the full-scale launch of the FDA-cleared system follows a successful limited rollout.
2. More than 100 patient levels were treated via both minimally invasive and open TLIF approaches during the limited rollout.
3. The system is designed to offer controlled, atraumatic insertion through a 6-8 mm cannula, which aims to minimize nerve retraction and mitigate implant migration.
4. At the NASS meeting, Benvenue Medical will also accept the 2015 Spine Technology Award for the Luna system in the Minimally Invasive Spine and Thoracolumbar Care categories.
More articles on devices:
FDA approves Mobi-C disc labeling update; includes 5-year study data: 6 things to know
Exactech launches Acapella One Cervical Spacer System: 5 key points
Life Spine releases devices for expandable lateral interbody fusions: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
